<DOC>
	<DOCNO>NCT02668380</DOCNO>
	<brief_summary>This Open Label , Prospective , Multicentre , Non-interventional Study Apatinib Chemotherapy-Refractory Advanced Metastatic Gastric Cancer , investigator opt give patient apatinib 850 mg daily , 28 day cycle . To evaluate safety efficacy apatinib Advanced Metastatic Gastric Cancer real world .</brief_summary>
	<brief_title>An Open Label , Prospective , Multicentre , Non-interventional Study Apatinib Chemotherapy-Refractory Advanced Metastatic Gastric Cancer</brief_title>
	<detailed_description>In last decade , front-line chemotherapy consider standard therapeutic regimen extension survival time patient metastatic gastric cancer ( mGC ) . New evidence suggest salvage chemo-therapies , second-line treatment , may survival advantage compare best supportive care . After failure second-line chemotherapy , result treatment poor , yield response rate 0 % 5 % evidence prolong survival . Apatinib small-molecule VEGFR-2 tyrosine kinase inhibitor , Had approve CFDA treatment advance gastric cancer , However , study defines variety inclusion/exclusion criterion , efficacy safety well reflect real world treatment advance gastric cancer . Therefore , Open Label , Prospective , Multicentre , Non-interventional Study could evaluate safety efficacy apatinib Advanced Metastatic Gastric Cancer real world .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>ã€‹18 year old Advanced Metastatic Gastric Cancer The doctor evaluate patient benefit treatment The patient sign write informed consent Apatinib confirm allergy sufferer Pregnant lactating woman Patients contraindication ( active bleeding , ulcer , intestinal perforation , intestinal obstruction , within 30 day major surgery , uncontrolled high blood pressure medication , IIIIV level cardiac insufficiency , severe liver kidney dysfunction ) Doctors think n't inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Apatinib</keyword>
	<keyword>metastatic gastric cancer</keyword>
	<keyword>Non-interventionalStudy</keyword>
</DOC>